We sell a diverse portfolio consisting of five promoted products and approximately 35 non-promoted products, several of which incorporate our proprietary Osmodex® drug delivery system. Our non-promoted product portfolio includes methylphenidate HCl ER tablets and venlafaxine HCl ER tablets and prescription and non-prescription dietary supplements.
We invite you to review the product websites and full prescribing information for more information.
Methylphenidate HCl ER 72 mg Tablets (M-72)
Osmolex ER™ (amantadine) Tablets
Lorzone® (chlorzoxazone USP) Tablet
ConZip® (tramadol hydrochloride) Extended-Release Capsules
Divigel® (estradiol gel) 0.1%
Patient safety is our highest priority, and it is our responsibility to monitor the safety of the products we develop. If you are a patient experiencing a potential adverse event or if you have questions about your condition, please contact your health care practitioner. To report an adverse event or a product complaint about our products, please contact us at:
Phone: 1-877-482-3788 or the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.